BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Degenhardt L, Charlson F, Stanaway J, Larney S, Alexander LT, Hickman M, Cowie B, Hall WD, Strang J, Whiteford H. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16:1385-1398. [PMID: 27665254 DOI: 10.1016/s1473-3099(16)30325-5] [Cited by in Crossref: 135] [Cited by in F6Publishing: 72] [Article Influence: 22.5] [Reference Citation Analysis]
Number Citing Articles
1 Grebely J, Dore GJ, Morin S, Rockstroh JK, Klein MB. Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there? J Int AIDS Soc. 2017;20:22146. [PMID: 28782335 DOI: 10.7448/ias.20.1.22146] [Cited by in Crossref: 74] [Cited by in F6Publishing: 32] [Article Influence: 14.8] [Reference Citation Analysis]
2 Hickman M, Larney S, Peacock A, Jones H, Grebely J, Degenhardt L. Competing global statistics on prevalence of injecting drug use: why does it matter and what can be done? Addiction 2018;113:1768-74. [PMID: 29989282 DOI: 10.1111/add.14383] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
3 GBD 2016 Alcohol and Drug Use Collaborators. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry 2018;5:987-1012. [PMID: 30392731 DOI: 10.1016/S2215-0366(18)30337-7] [Cited by in Crossref: 311] [Cited by in F6Publishing: 128] [Article Influence: 77.8] [Reference Citation Analysis]
4 Socías ME, Ti L, Wood E, Nosova E, Hull M, Hayashi K, Debeck K, Milloy MJ. Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting. Liver Int 2019;39:1400-7. [PMID: 30653809 DOI: 10.1111/liv.14043] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
5 Arum C, Fraser H, Artenie AA, Bivegete S, Trickey A, Alary M, Astemborski J, Iversen J, Lim AG, MacGregor L, Morris M, Ong JJ, Platt L, Sack-Davis R, van Santen DK, Solomon SS, Sypsa V, Valencia J, Van Den Boom W, Walker JG, Ward Z, Stone J, Vickerman P; Homelessness, HIV, and HCV Review Collaborative Group. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Public Health 2021;6:e309-23. [PMID: 33780656 DOI: 10.1016/S2468-2667(21)00013-X] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
6 Mansberg K, Kull K, Salupere R, Prükk T, Margus B, Kariis T, Remmel T, Suurmaa K, Ott K, Jaago K, Šmidt J. A Population-Based Surveillance Study on the Epidemiology of Hepatitis C in Estonia. Medicina (Kaunas) 2018;54:E9. [PMID: 30344240 DOI: 10.3390/medicina54010009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Falade-Nwulia O, Gicquelais RE, Astemborski J, McCormick SD, Kirk G, Sulkowski M, Thomas DL, Mehta SH. Hepatitis C treatment uptake among people who inject drugs in the oral direct-acting antiviral era. Liver Int 2020;40:2407-16. [PMID: 32770638 DOI: 10.1111/liv.14634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Grebely J, Bruneau J, Lazarus JV, Dalgard O, Bruggmann P, Treloar C, Hickman M, Hellard M, Roberts T, Crooks L. Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs. Int J Drug Policy. 2017;47:51-60. [PMID: 28683982 DOI: 10.1016/j.drugpo.2017.05.019] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
9 Barnhart DA, Kamali I, Nyirahabihirwe F, Mugabo C, Gakuru JP, Uwase M, Nizeyumuremyi E, Musafiri T, Gatete JD, Makuza JD, Kateera F, Hedt-Gauthier B, Ndahimana JD. Knowledge among patients with Hepatitis C initiating on direct-acting antiviral treatment in rural Rwanda: A prospective cohort study. Glob Health Action 2021;14:1953250. [PMID: 34347569 DOI: 10.1080/16549716.2021.1953250] [Reference Citation Analysis]
10 Horwood J, Clement C, Roberts K, Waldron CA, Irving WL, Macleod J, Hickman M. Increasing uptake of hepatitis C virus infection case-finding, testing, and treatment in primary care: evaluation of the HepCATT (Hepatitis C Assessment Through to Treatment) trial. Br J Gen Pract 2020;70:e581-8. [PMID: 32094220 DOI: 10.3399/bjgp20X708785] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Schröeder SE, Pedrana A, Scott N, Wilson D, Kuschel C, Aufegger L, Atun R, Baptista-Leite R, Butsashvili M, El-Sayed M, Getahun A, Hamid S, Hammad R, 't Hoen E, Hutchinson SJ, Lazarus JV, Lesi O, Li W, Binti Mohamed R, Olafsson S, Peck R, Sohn AH, Sonderup M, Spearman CW, Swan T, Thursz M, Walker T, Hellard M, Howell J. Innovative strategies for the elimination of viral hepatitis at a national level: A country case series. Liver Int 2019;39:1818-36. [PMID: 31433902 DOI: 10.1111/liv.14222] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
12 Lewer D, Hope VD, Harris M, Kelleher M, Jewell A, Pritchard M, Strang J, Morley KI. Incidence and treatment costs of severe bacterial infections among people who inject heroin: A cohort study in South London, England. Drug Alcohol Depend 2020;212:108057. [PMID: 32422537 DOI: 10.1016/j.drugalcdep.2020.108057] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
13 Rudzinski K, Xavier J, Guta A, Chan Carusone S, King K, Phillips JC, Switzer S, O'Leary B, Baltzer Turje R, Harrison S, de Prinse K, Simons J, Strike C. Feasibility, acceptability, concerns, and challenges of implementing supervised injection services at a specialty HIV hospital in Toronto, Canada: perspectives of people living with HIV. BMC Public Health 2021;21:1482. [PMID: 34325681 DOI: 10.1186/s12889-021-11507-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Miller WC, Hoffman IF, Hanscom BS, Ha TV, Dumchev K, Djoerban Z, Rose SM, Latkin CA, Metzger DS, Lancaster KE, Go VF, Dvoriak S, Mollan KR, Reifeis SA, Piwowar-Manning EM, Richardson P, Hudgens MG, Hamilton EL, Sugarman J, Eshleman SH, Susami H, Chu VA, Djauzi S, Kiriazova T, Bui DD, Strathdee SA, Burns DN. A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study. Lancet 2018;392:747-59. [PMID: 30191830 DOI: 10.1016/S0140-6736(18)31487-9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
15 Laprise C, Bolster-Foucault C. Understanding barriers and facilitators to HIV testing in Canada from 2009-2019: A systematic mixed studies review. Can Commun Dis Rep 2021;47:105-25. [PMID: 33746619 DOI: 10.14745/ccdr.v47i02a03] [Reference Citation Analysis]
16 Trickey A, Semchuk N, Saliuk T, Sazonova Y, Varetska O, Walker JG, Lim AG, Stone J, Vickerman P. Has resourcing of non-governmental harm-reduction organizations in Ukraine improved HIV prevention and treatment outcomes for people who inject drugs? Findings from multiple bio-behavioural surveys. J Int AIDS Soc 2020;23:e25608. [PMID: 32851812 DOI: 10.1002/jia2.25608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Marotta PL, Gilbert L, Terlikbayeva A, Wu E, El-Bassel N. Differences by sex in associations between injection drug risks and drug crime conviction among people who inject drugs in Almaty, Kazakhstan. Int J Drug Policy 2018;60:96-106. [PMID: 30219718 DOI: 10.1016/j.drugpo.2018.07.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sharhani A, Jorjoran Shushtari Z, Rahmani A, Armoon B, Noroozi M, Ahounbar E, Karimi SE, Higgs P. Incidence of HIV and HCV in people who inject drugs: a systematic and meta-analysis review protocol. BMJ Open 2021;11:e041482. [PMID: 33452193 DOI: 10.1136/bmjopen-2020-041482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Fadnes LT, Aas CF, Vold JH, Leiva RA, Ohldieck C, Chalabianloo F, Skurtveit S, Lygren OJ, Dalgård O, Vickerman P, Midgard H, Løberg EM, Johansson KA; INTRO-HCV Study Group. Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV). PLoS Med 2021;18:e1003653. [PMID: 34061883 DOI: 10.1371/journal.pmed.1003653] [Reference Citation Analysis]
20 Ahmad NJ, Allen ST, White RH, Schneider KE, O'Rourke A, Perdue M, Babcock C, Kilkenny ME, Sherman SG. Correlates of recent nonfatal overdose among people who inject drugs in West Virginia. Harm Reduct J 2021;18:22. [PMID: 33602226 DOI: 10.1186/s12954-021-00470-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Al-Brhami KAR, Abdul-Ghani R, Al-Qobati SA. Intestinal microsporidiosis among HIV/AIDS patients receiving antiretroviral therapy in Sana'a city, Yemen: first report on prevalence and predictors. BMC Infect Dis 2022;22:11. [PMID: 34983416 DOI: 10.1186/s12879-021-07009-3] [Reference Citation Analysis]
22 Mohamed Z, Scott N, Nayagam S, Rwegasha J, Mbwambo J, Thursz MR, Brown AS, Hellard M, Lemoine M. Cost effectiveness of simplified HCV screening-and-treatment interventions for people who inject drugs in Dar-es-Salaam, Tanzania. Int J Drug Policy 2021;99:103458. [PMID: 34624732 DOI: 10.1016/j.drugpo.2021.103458] [Reference Citation Analysis]
23 Bao Y, Larney S, Peacock A, Colledge S, Grebely J, Hickman M, Degenhardt L, Leung J. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis. Int J Drug Policy 2019;70:87-93. [PMID: 31125802 DOI: 10.1016/j.drugpo.2019.05.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
24 Stewart AC, Cossar R, Lee Wilkinson A, Scott N, Dietze P, Quinn B, Kinner SA, Aitken C, Walker S, Curtis M, Butler T, Ogloff JRP, Stoové M. Psychiatric well-being among men leaving prison reporting a history of injecting drug use: A longitudinal analysis. Aust N Z J Psychiatry 2021;:48674211048143. [PMID: 34558314 DOI: 10.1177/00048674211048143] [Reference Citation Analysis]
25 Arends RM, Nelwan EJ, Soediro R, van Crevel R, Alisjahbana B, Pohan HT, von Borries AKL, Schene AH, van der Ven AJAM, Schellekens AFA. Associations between impulsivity, risk behavior and HIV, HBV, HCV and syphilis seroprevalence among female prisoners in Indonesia: A cross-sectional study. PLoS One 2019;14:e0207970. [PMID: 30768609 DOI: 10.1371/journal.pone.0207970] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
26 Mazhnaya A, Meteliuk A, Barnard T, Zelenev A, Filippovych S, Altice FL. Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes. Int J Drug Policy 2017;47:187-95. [PMID: 28811159 DOI: 10.1016/j.drugpo.2017.07.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
27 Ferraro CF, Stewart DE, Grebely J, Tran LT, Zhou S, Puca C, Hajarizadeh B, Larney S, Santo T Jr, Higgins JPT, Vickerman P, Degenhardt L, Hickman M, French CE. Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysis. Addiction 2021;116:1664-76. [PMID: 33140543 DOI: 10.1111/add.15316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Jordan AE, Perlman DC, Reed J, Smith DJ, Hagan H. Patterns and Gaps Identified in a Systematic Review of the Hepatitis C Virus Care Continuum in Studies among People Who Use Drugs. Front Public Health 2017;5:348. [PMID: 29326922 DOI: 10.3389/fpubh.2017.00348] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
29 Fernández de Cañete Camacho JC, Mancebo Martínez A, García Mena MA, Moreno Planas JM. Influence of psychiatric disorders and opioid substitution therapy on hepatitis C treatment with direct-acting antivirals in people who inject drugs. Gastroenterol Hepatol 2021:S0210-5705(21)00251-X. [PMID: 34543719 DOI: 10.1016/j.gastrohep.2021.09.003] [Reference Citation Analysis]
30 Walker JG, Kuchuloria T, Sergeenko D, Fraser H, Lim AG, Shadaker S, Hagan L, Gamkrelidze A, Kvaratskhelia V, Gvinjilia L, Aladashvili M, Asatiani A, Baliashvili D, Butsashvili M, Chikovani I, Khonelidze I, Kirtadze I, Kuniholm MH, Otiashvili D, Sharvadze L, Stvilia K, Tsertsvadze T, Zakalashvili M, Hickman M, Martin NK, Morgan J, Nasrullah M, Averhoff F, Vickerman P. Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study. Lancet Glob Health. 2020;8:e244-e253. [PMID: 31864917 DOI: 10.1016/s2214-109x(19)30483-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
31 Mukherjee TI, Pillai V, Ali SH, Altice FL, Kamarulzaman A, Wickersham JA. Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia. Int J Drug Policy 2017;47:144-52. [PMID: 28652072 DOI: 10.1016/j.drugpo.2017.05.041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
32 Le LN, O'Connor S, Tran TH, Maher L, Kaldor J, Sabin K, Tran HV, Tran QD, Ho VAT, Nguyen TA. High hepatitis C virus infection among female sex workers in Viet Nam: strong correlation with HIV and injection drug use. Western Pac Surveill Response J 2019;10:9-18. [PMID: 32110460 DOI: 10.5365/wpsar.2019.10.1.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Lim AG, Trickey A, Thompson LH, Emmanuel F, Reza TE, Reynolds R, Cholette F, Melesse DY, Archibald C, Sandstrom P, Blanchard JF, Vickerman P. Elucidating Drivers for Variations in the Explosive Human Immunodeficiency Virus Epidemic Among People Who Inject Drugs in Pakistan. Open Forum Infect Dis 2021;8:ofab457. [PMID: 34584901 DOI: 10.1093/ofid/ofab457] [Reference Citation Analysis]
34 Adewuyi EO, Auta A. Medical injection and access to sterile injection equipment in low- and middle-income countries: a meta-analysis of Demographic and Health Surveys (2010-2017). Int Health 2020;12:388-94. [PMID: 31851322 DOI: 10.1093/inthealth/ihz113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Sekiba K, Otsuka M, Ohno M, Yamagami M, Kishikawa T, Suzuki T, Ishibashi R, Seimiya T, Tanaka E, Koike K. Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA. World J Gastroenterol 2018; 24(21): 2261-2268 [PMID: 29881235 DOI: 10.3748/wjg.v24.i21.2261] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
36 Pereira VRZB, Wolf JM, Luz CADS, Stumm GZ, Boeira TDR, Galvan J, Simon D, Lunge VR. Risk factors for hepatitis B transmission in South Brazil. Mem Inst Oswaldo Cruz 2017;112:544-50. [PMID: 28767979 DOI: 10.1590/0074-02760170043] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
37 Genberg BL, Astemborski J, Treisman G, Anagnostopoulos A, Mehta SH, Kirk GD, Abraham A. Engagement in treatment for depression among people who inject drugs in Baltimore, Maryland. J Subst Abuse Treat 2019;106:107-12. [PMID: 31540605 DOI: 10.1016/j.jsat.2019.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
38 Crowley D, Homeniuk R, Delargy I. Scoping review protocol: the use of telemedicine in providing opioid agonist treatment and related psychosocial supports. BMJ Open 2020;10:e040556. [PMID: 33277286 DOI: 10.1136/bmjopen-2020-040556] [Reference Citation Analysis]
39 Crowley D, Delargy I. A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report. Harm Reduct J 2020;17:49. [PMID: 32680520 DOI: 10.1186/s12954-020-00394-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
40 Peng L, Wu YL. Immunotherapy in the Asiatic population: any differences from Caucasian population? J Thorac Dis 2018;10:S1482-93. [PMID: 29951300 DOI: 10.21037/jtd.2018.05.106] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
41 Yang J, Zhang Y, Luo L, Meng R, Yu C. Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990-2016: An Age-Period-Cohort and Spatial Autocorrelation Analysis. Int J Environ Res Public Health 2018;15:E170. [PMID: 29361804 DOI: 10.3390/ijerph15010170] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
42 Baum MK, Tamargo JA, Ehman RL, Sherman KE, Chen J, Liu Q, Mandler RN, Teeman C, Martinez SS, Campa A. Heroin use is associated with liver fibrosis in the Miami Adult Studies on HIV (MASH) cohort. Drug Alcohol Depend 2021;220:108531. [PMID: 33508691 DOI: 10.1016/j.drugalcdep.2021.108531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Christensen S, Buggisch P, Mauss S, Böker KH, Müller T, Klinker H, Zimmermann T, Serfert Y, Weber B, Reimer J, Wedemeyer H; German Hepatitis C-Registry. Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy-Data From the German Hepatitis C-Registry (DHC-R). Subst Abuse 2019;13:1178221819835847. [PMID: 30944519 DOI: 10.1177/1178221819835847] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
44 Chan Carusone S, Guta A, Robinson S, Tan DH, Cooper C, O'Leary B, de Prinse K, Cobb G, Upshur R, Strike C. "Maybe if I stop the drugs, then maybe they'd care?"-hospital care experiences of people who use drugs. Harm Reduct J 2019;16:16. [PMID: 30760261 DOI: 10.1186/s12954-019-0285-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
45 Zhang C, Ren Q, Chang W. Epidemiological Features and Risk Factors for Acquiring Hepatitis B, Hepatitis C, and Syphilis in HIV-Infected Patients in Shaanxi Province, Northwest China. Int J Environ Res Public Health 2020;17:E1990. [PMID: 32197326 DOI: 10.3390/ijerph17061990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Sypsa V, Flounzi E, Roussos S, Hatzakis A, Benetou V. Food insecurity among people who inject drugs in Athens, Greece: a study in the context of ARISTOTLE programme. Public Health Nutr 2021;24:813-8. [PMID: 33100259 DOI: 10.1017/S1368980020004309] [Reference Citation Analysis]
47 Topkaya N, Şahin E, Krettmann AK, Essau CA. Stigmatization of people with alcohol and drug addiction among Turkish undergraduate students. Addict Behav Rep 2021;14:100386. [PMID: 34938844 DOI: 10.1016/j.abrep.2021.100386] [Reference Citation Analysis]
48 Roberts K, Macleod J, Metcalfe C, Hollingworth W, Williams J, Muir P, Vickerman P, Clement C, Gordon F, Irving W, Waldron CA, North P, Moore P, Simmons R, Miners A, Horwood J, Hickman M. Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care. BMJ 2020;368:m322. [PMID: 32102782 DOI: 10.1136/bmj.m322] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
49 Idrisov B, Lunze K, Cheng DM, Blokhina E, Gnatienko N, Quinn E, Bridden C, Walley AY, Bryant KJ, Lioznov D, Krupitsky E, Samet JH. Role of substance use in HIV care cascade outcomes among people who inject drugs in Russia. Addict Sci Clin Pract 2017;12:30. [PMID: 29198185 DOI: 10.1186/s13722-017-0098-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
50 Marotta PL, Terlikbayeva A, Gilbert L, Hunt T, Mandavia A, Wu E, El-Bassel N. Intimate relationships and patterns of drug and sexual risk behaviors among people who inject drugs in Kazakhstan: A latent class analysis. Drug Alcohol Depend 2018;192:294-302. [PMID: 30304712 DOI: 10.1016/j.drugalcdep.2018.07.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
51 Falade-Nwulia O, Ward KM, McCormick S, Mehta SH, Pitts SR, Katz S, Chander G, Thomas DL, Sulkowski M, Latkin CA. Network-based recruitment of people who inject drugs for hepatitis C testing and linkage to care. J Viral Hepat 2020;27:663-70. [PMID: 32045086 DOI: 10.1111/jvh.13274] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
52 Sorge JT, Young M, Maloney-Hall B, Sherk A, Kent P, Zhao J, Stockwell T, Perlova K, Macdonald S, Ferguson B. Estimation of the impacts of substance use on workplace productivity: a hybrid human capital and prevalence-based approach applied to Canada. Can J Public Health 2020;111:202-11. [PMID: 31792845 DOI: 10.17269/s41997-019-00271-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
53 Damas J, Storm M, Pandey LR, Marrone G, Deuba K. Prevalence of HIV, Hepatitis C and its related risk behaviours among women who inject drugs in the Kathmandu Valley, Nepal: a cross-sectional study. Ther Adv Infect Dis 2021;8:20499361211062107. [PMID: 34881024 DOI: 10.1177/20499361211062107] [Reference Citation Analysis]
54 Karimi SE, Bayani A, Higgs P, Bayat AH, Hemmat M, Ahounbar E, Armoon B, Fakhri Y. Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and Meta-analysis. Subst Abuse Treat Prev Policy 2020;15:64. [PMID: 32831107 DOI: 10.1186/s13011-020-00306-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
55 Lancaster KE, Mollan KR, Hanscom BS, Shook-Sa BE, Ha TV, Dumchev K, Djoerban Z, Rose SM, Latkin CA, Metzger DS, Go VF, Dvoriak S, Reifeis SA, Piwowar-Manning EM, Richardson P, Hudgens MG, Hamilton EL, Eshleman SH, Susami H, Chu VA, Djauzi S, Kiriazova T, Nhan DT, Burns DN, Miller WC, Hoffman IF. Engaging People Who Inject Drugs Living With HIV in Antiretroviral Treatment and Medication for Opioid Use Disorder: Extended Follow-up of HIV Prevention Trials Network (HPTN) 074. Open Forum Infect Dis 2021;8:ofab281. [PMID: 34458390 DOI: 10.1093/ofid/ofab281] [Reference Citation Analysis]
56 Ishizaki A, Tran VT, Nguyen CH, Tanimoto T, Hoang HTT, Pham HV, Phan CTT, Bi X, Pham TV, Ichimura H. Discrepancies in prevalence trends for HIV, hepatitis B virus, and hepatitis C virus in Haiphong, Vietnam from 2007 to 2012. PLoS One. 2017;12:e0179616. [PMID: 28662105 DOI: 10.1371/journal.pone.0179616] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
57 Baker P, Beletsky L, Avalos L, Venegas C, Rivera C, Strathdee SA, Cepeda J. Policing Practices and Risk of HIV Infection Among People Who Inject Drugs. Epidemiol Rev 2020;42:27-40. [PMID: 33184637 DOI: 10.1093/epirev/mxaa010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
58 Larney S, Hickman M, Guy R, Grebely J, Dore GJ, Gray RT, Day CA, Kimber J, Degenhardt L. Estimating the number of people who inject drugs in Australia. BMC Public Health 2017;17:757. [PMID: 28962604 DOI: 10.1186/s12889-017-4785-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
59 Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, Stone J, Cunningham EB, Trickey A, Dumchev K, Lynskey M, Griffiths P, Mattick RP, Hickman M, Larney S. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5:e1192-e1207. [PMID: 29074409 DOI: 10.1016/s2214-109x(17)30375-3] [Cited by in Crossref: 539] [Cited by in F6Publishing: 287] [Article Influence: 107.8] [Reference Citation Analysis]
60 Martin NK, Boerekamps A, Hill AM, Rijnders BJA. Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it? J Int AIDS Soc 2018;21 Suppl 2:e25062. [PMID: 29633560 DOI: 10.1002/jia2.25062] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 9.7] [Reference Citation Analysis]
61 Abdulrazzak MH, Alsahybi AH, Assabri A, Khader Y. Evaluation of HIV Reporting Form in Sana'a City, Yemen, 2016. Inquiry 2019;56:46958019847020. [PMID: 31064261 DOI: 10.1177/0046958019847020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Richardson D, Bell C. Public health interventions for reducing HIV, hepatitis B and hepatitis C infections in people who inject drugs. Public Health Action 2018;8:153. [PMID: 30775273 DOI: 10.5588/pha.18.0093-ed] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Midgard H, Finbråten AK, Malme KB, Berg-Pedersen RM, Tanum L, Olsen IC, Bjørnestad R, Dalgard O. Opportunistic treatment of hepatitis C virus infection (OPPORTUNI-C): study protocol for a pragmatic stepped wedge cluster randomized trial of immediate versus outpatient treatment initiation among hospitalized people who inject drugs. Trials 2020;21:524. [PMID: 32539853 DOI: 10.1186/s13063-020-04434-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Morozova O, Cohen T, Crawford FW. Risk ratios for contagious outcomes. J R Soc Interface 2018;15:20170696. [PMID: 29343627 DOI: 10.1098/rsif.2017.0696] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
65 Miller K, Treloar C, Lloyd AR. People in prison who inject drugs: who is trusted when it comes to information about hepatitis C? Addiction Research & Theory 2021;29:247-54. [DOI: 10.1080/16066359.2021.1879058] [Reference Citation Analysis]
66 Trickey A, Fraser H, Lim AG, Peacock A, Colledge S, Walker JG, Leung J, Grebely J, Larney S, Martin NK, Hickman M, Degenhardt L, May MT, Vickerman P. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study. Lancet Gastroenterol Hepatol 2019;4:435-44. [PMID: 30981685 DOI: 10.1016/S2468-1253(19)30085-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 23] [Article Influence: 17.3] [Reference Citation Analysis]
67 Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, Jordan A, Degenhardt L, Hope V, Hutchinson S, Maher L, Palmateer N, Taylor A, Bruneau J, Hickman M. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis. Addiction. 2018;113:545-563. [PMID: 28891267 DOI: 10.1111/add.14012] [Cited by in Crossref: 142] [Cited by in F6Publishing: 138] [Article Influence: 28.4] [Reference Citation Analysis]
68 Liang J, Nosova E, Reddon H, Nolan S, Socías E, Barrios R, Milloy MJ. Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs. AIDS 2020;34:1389-96. [PMID: 32590435 DOI: 10.1097/QAD.0000000000002551] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
69 Rostam-Abadi Y, Rafiemanesh H, Gholami J, Shadloo B, Amin-Esmaeili M, Rahimi-Movaghar A. Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis. Harm Reduct J 2020;17:81. [PMID: 33087141 DOI: 10.1186/s12954-020-00424-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Maina G, Marshall K, Sherstobitof J. Untangling the Complexities of Substance Use Initiation and Recovery: Client Reflections on Opioid Use Prevention and Recovery From a Social-Ecological Perspective. Subst Abuse 2021;15:11782218211050372. [PMID: 34675526 DOI: 10.1177/11782218211050372] [Reference Citation Analysis]
71 McDonald R, Lorch U, Woodward J, Bosse B, Dooner H, Mundin G, Smith K, Strang J. Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: Phase I healthy volunteer study. Addiction 2018;113:484-93. [PMID: 29143400 DOI: 10.1111/add.14033] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 8.6] [Reference Citation Analysis]
72 Fraser H, Zibbell J, Hoerger T, Hariri S, Vellozzi C, Martin NK, Kral AH, Hickman M, Ward JW, Vickerman P. Scaling-up HCV prevention and treatment interventions in rural United States-model projections for tackling an increasing epidemic. Addiction. 2018;113:173-182. [PMID: 28734093 DOI: 10.1111/add.13948] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 12.2] [Reference Citation Analysis]
73 Crowley D, Van Hout MC, Murphy C, Kelly E, Lambert JS, Cullen W. Hepatitis C virus screening and treatment in Irish prisons from nurse managers' perspectives - a qualitative exploration. BMC Nurs 2019;18:23. [PMID: 31210751 DOI: 10.1186/s12912-019-0347-x] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
74 Jain N, Avanthika C, Singh A, Jhaveri S, De la Hoz I, Hassen G, Camacho L GP, Carrera KG. Deep Vein Thrombosis in Intravenous Drug Users: An Invisible Global Health Burden. Cureus 2021;13:e18457. [PMID: 34745781 DOI: 10.7759/cureus.18457] [Reference Citation Analysis]
75 Meissner EG. Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era. Curr Opin Gastroenterol 2017;33:120-7. [PMID: 28234770 DOI: 10.1097/MOG.0000000000000347] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
76 Fadnes LT, Aas CF, Vold JH, Ohldieck C, Leiva RA, Chalabianloo F, Skurtveit S, Lygren OJ, Dalgård O, Vickerman P, Midgard H, Løberg EM, Johansson KA; INTRO-HCV Study Group. Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV). BMC Infect Dis 2019;19:943. [PMID: 31703669 DOI: 10.1186/s12879-019-4598-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
77 Kelly SM, Schwartz RP, O'Grady KE, Mitchell SG, Duren T, Sharma A, Jaffe JH. Impact of methadone treatment initiated in jail on subsequent arrest. J Subst Abuse Treat 2020;113:108006. [PMID: 32359668 DOI: 10.1016/j.jsat.2020.108006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
78 Torres HA, Shigle TL, Hammoudi N, Link JT, Samaniego F, Kaseb A, Mallet V. The oncologic burden of hepatitis C virus infection: A clinical perspective. CA Cancer J Clin. 2017;67:411-431. [PMID: 28683174 DOI: 10.3322/caac.21403] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 9.8] [Reference Citation Analysis]
79 Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, Trickey A, Abbott S, Strathdee SA, Abramovitz D, Maher L, Iversen J, Bruneau J, Zang G, Garfein RS, Yen YF, Azim T, Mehta SH, Milloy MJ, Hellard ME, Sacks-Davis R, Dietze PM, Aitken C, Aladashvili M, Tsertsvadze T, Mravčík V, Alary M, Roy E, Smyrnov P, Sazonova Y, Young AM, Havens JR, Hope VD, Desai M, Heinsbroek E, Hutchinson SJ, Palmateer NE, McAuley A, Platt L, Martin NK, Altice FL, Hickman M, Vickerman P. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis 2018;18:1397-409. [PMID: 30385157 DOI: 10.1016/S1473-3099(18)30469-9] [Cited by in Crossref: 63] [Cited by in F6Publishing: 33] [Article Influence: 15.8] [Reference Citation Analysis]
80 Hutin YJ, Bulterys M, Hirnschall GO. How far are we from viral hepatitis elimination service coverage targets? J Int AIDS Soc. 2018;21 Suppl 2:e25050. [PMID: 29633520 DOI: 10.1002/jia2.25050] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 12.0] [Reference Citation Analysis]